Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies

被引:0
|
作者
Laure Thibaudeau
Verena M. Quent
Boris M. Holzapfel
Anna V. Taubenberger
Melanie Straub
Dietmar W. Hutmacher
机构
[1] Queensland University of Technology,Regenerative Medicine Group, Institute of Health and Biomedical Innovation
[2] University Hospital Erlangen,Department of Obstetrics and Gynecology
[3] Friedrich-Alexander University Erlangen-Nuremberg,Orthopedic Center for Musculoskeletal Research
[4] University of Wuerzburg,George W Woodruff School of Mechanical Engineering
[5] Biotec TU Dresden,undefined
[6] Institute of Pathology,undefined
[7] Technical University Munich,undefined
[8] Georgia Institute of Technology,undefined
[9] Institute for Advanced Study,undefined
[10] Technical University Munich,undefined
来源
Cancer and Metastasis Reviews | 2014年 / 33卷
关键词
Bone metastasis; Breast cancer; Osteotropism; Humanized xenograft model; Tissue engineering;
D O I
暂无
中图分类号
学科分类号
摘要
Bone metastasis is a complication that occurs in 80 % of women with advanced breast cancer. Despite the prevalence of bone metastatic disease, the avenues for its clinical management are still restricted to palliative treatment options. In fact, the underlying mechanisms of breast cancer osteotropism have not yet been fully elucidated due to a lack of suitable in vivo models that are able to recapitulate the human disease. In this work, we review the current transplantation-based models to investigate breast cancer-induced bone metastasis and delineate the strengths and limitations of the use of different grafting techniques, tissue sources, and hosts. We further show that humanized xenograft models incorporating human cells or tissue grafts at the primary tumor site or the metastatic site mimic more closely the human disease. Tissue-engineered constructs are emerging as a reproducible alternative to recapitulate functional humanized tissues in these murine models. The development of advanced humanized animal models may provide better platforms to investigate the mutual interactions between human cancer cells and their microenvironment and ultimately improve the translation of preclinical drug trials to the clinic.
引用
收藏
页码:721 / 735
页数:14
相关论文
共 50 条
  • [21] A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
    Dai, Jianxin
    Li, Bohua
    Shi, Jinping
    Peng, Ling
    Zhang, Dapeng
    Qian, Weizhu
    Hou, Sheng
    Zhao, Lei
    Gao, Jie
    Cao, Zhiguo
    Zhao, Jian
    Wang, Hao
    Guo, Yajun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (03) : 355 - 366
  • [22] A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
    Jianxin Dai
    Bohua Li
    Jinping Shi
    Ling Peng
    Dapeng Zhang
    Weizhu Qian
    Sheng Hou
    Lei Zhao
    Jie Gao
    Zhiguo Cao
    Jian Zhao
    Hao Wang
    Yajun Guo
    Cancer Immunology, Immunotherapy, 2010, 59 : 355 - 366
  • [23] Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
    Zinonos, Irene
    Luo, Ke-Wang
    Labrinidis, Agatha
    Liapis, Vasilios
    Hay, Shelley
    Panagopoulos, Vasilios
    Denichilo, Mark
    Ko, Chun-Hay
    Yue, Grace Gar-Lee
    Lau, Clara Bik-San
    Ingman, Wendy
    Ponomarev, Vladimir
    Atkins, Gerald J.
    Findlay, David M.
    Zannettino, Andrew C. W.
    Evdokiou, Andreas
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 532 - 540
  • [24] Nanotheranostics in Breast Cancer Bone Metastasis: Advanced Research Progress and Future Perspectives
    Miao, Lin
    Zhu, Yidan
    Chang, Hong
    Zhang, Xinfeng
    PHARMACEUTICS, 2024, 16 (12)
  • [25] Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
    Pang, Lulian
    Gan, Chen
    Xu, Jian
    Jia, Yingxue
    Chai, Jiaying
    Huang, Runze
    Li, Anlong
    Ge, Han
    Yu, Sheng
    Cheng, Huaidong
    CANCERS, 2022, 14 (23)
  • [26] Phytochemicals in Breast Cancer-Induced Osteoclastogenesis and Bone Resorption: Mechanism and Future Perspective
    Pore, Subrata Kumar
    Hahm, Eun-Ryeong
    CURRENT PHARMACOLOGY REPORTS, 2022, 8 (02) : 130 - 148
  • [27] Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of zoledronic acid in vivo
    Landgraf, Marietta
    Lahr, Christoph A.
    Sanchez-Herrero, Alvaro
    Meinert, Christoph
    Shokoohmand, Ali
    Pollock, Pamela M.
    Hutmacher, Dietmar W.
    Shafiee, Abbas
    McGovern, Jacqui A.
    BONE RESEARCH, 2019, 7 (1)
  • [28] Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts
    Diane Lefley
    Faith Howard
    Fawaz Arshad
    Steven Bradbury
    Hannah Brown
    Claudia Tulotta
    Rachel Eyre
    Denis Alférez
    J. Mark Wilkinson
    Ingunn Holen
    Robert B. Clarke
    Penelope Ottewell
    Breast Cancer Research, 21
  • [29] MicroRNA-506 ameliorates breast cancer-induced osteolytic bone metastasis via the NFATc-1 signaling pathway
    Lv, Feng
    Qin, Jingbo
    Kong, Shuxin
    Pan, Limin
    Ding, Ran
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36 (10)
  • [30] Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
    Zhai, Zanjing
    Qu, Xinhua
    Yan, Wei
    Li, Haowei
    Liu, Guangwang
    Liu, Xuqiang
    Tang, Tingting
    Qin, An
    Dai, Kerong
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (01) : 33 - 45